JNJ-7777120 is a drug being developed by Johnson & Johnson Pharmaceutical Research & Development which acts as a potent and selective antagonist at the histamine H4 receptor. It has antiinflammatory effects and has been demonstrated to be superior to traditional antihistamines in the treatment of pruritus (itching).
This page contains content from the copyrighted Wikipedia article "JNJ-7777120"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
